Cargando…

Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)

Introduction: Neonatal Abstinence Syndrome (NAS) is considered a Public Health problem that is defined as a group of symptoms that appear in the newborn due to withdrawal from intrauterine drug exposure. Objective: The aim of this study was to analyze the incidence of NAS in Castilla y León from 200...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno-Ramos, Miriam, Sánchez-Barba, Mercedes, Sánchez, Rubén García, Mirón-Canelo, José Antonio, González-Nuñez, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774299/
https://www.ncbi.nlm.nih.gov/pubmed/35053650
http://dx.doi.org/10.3390/children9010025
_version_ 1784636305286627328
author Moreno-Ramos, Miriam
Sánchez-Barba, Mercedes
Sánchez, Rubén García
Mirón-Canelo, José Antonio
González-Nuñez, Veronica
author_facet Moreno-Ramos, Miriam
Sánchez-Barba, Mercedes
Sánchez, Rubén García
Mirón-Canelo, José Antonio
González-Nuñez, Veronica
author_sort Moreno-Ramos, Miriam
collection PubMed
description Introduction: Neonatal Abstinence Syndrome (NAS) is considered a Public Health problem that is defined as a group of symptoms that appear in the newborn due to withdrawal from intrauterine drug exposure. Objective: The aim of this study was to analyze the incidence of NAS in Castilla y León from 2000 to 2019. Methodology: Data of NAS cases in Castilla y León from 2000 to 2019 were obtained. NAS incidence per 1000 births was calculated and the correlation among data from different provinces and years was analyzed. Results: The cumulative incidence of NAS in Castilla y León per 1000 births between 2000-2019 was 0.91‰, with great interprovincial variability. The provinces of Zamora and Palencia stand out, with high incidence rates of NAS despite their low birth rates. The temporal trend points towards a decrease in incidence from 2000 to 2019. Opioids such as methadone, cannabis, benzodiazepines and poly-drug use are the most prevalent drugs causing NAS, and it has also been observed that methadone is being replaced by cannabis as the major cause of NAS cases at the University Hospital in Salamanca in recent years. Conclusions: The incidence of NAS in Castilla y León decreased in 2004 and remained constant until 2019, but it shows great interprovincial variability. It is necessary to implement a national NAS Registry to obtain comprehensive information regarding its incidence.
format Online
Article
Text
id pubmed-8774299
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87742992022-01-21 Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain) Moreno-Ramos, Miriam Sánchez-Barba, Mercedes Sánchez, Rubén García Mirón-Canelo, José Antonio González-Nuñez, Veronica Children (Basel) Article Introduction: Neonatal Abstinence Syndrome (NAS) is considered a Public Health problem that is defined as a group of symptoms that appear in the newborn due to withdrawal from intrauterine drug exposure. Objective: The aim of this study was to analyze the incidence of NAS in Castilla y León from 2000 to 2019. Methodology: Data of NAS cases in Castilla y León from 2000 to 2019 were obtained. NAS incidence per 1000 births was calculated and the correlation among data from different provinces and years was analyzed. Results: The cumulative incidence of NAS in Castilla y León per 1000 births between 2000-2019 was 0.91‰, with great interprovincial variability. The provinces of Zamora and Palencia stand out, with high incidence rates of NAS despite their low birth rates. The temporal trend points towards a decrease in incidence from 2000 to 2019. Opioids such as methadone, cannabis, benzodiazepines and poly-drug use are the most prevalent drugs causing NAS, and it has also been observed that methadone is being replaced by cannabis as the major cause of NAS cases at the University Hospital in Salamanca in recent years. Conclusions: The incidence of NAS in Castilla y León decreased in 2004 and remained constant until 2019, but it shows great interprovincial variability. It is necessary to implement a national NAS Registry to obtain comprehensive information regarding its incidence. MDPI 2021-12-30 /pmc/articles/PMC8774299/ /pubmed/35053650 http://dx.doi.org/10.3390/children9010025 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Moreno-Ramos, Miriam
Sánchez-Barba, Mercedes
Sánchez, Rubén García
Mirón-Canelo, José Antonio
González-Nuñez, Veronica
Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
title Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
title_full Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
title_fullStr Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
title_full_unstemmed Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
title_short Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
title_sort incidence of neonatal abstinence syndrome (nas) in castilla y leon (spain)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774299/
https://www.ncbi.nlm.nih.gov/pubmed/35053650
http://dx.doi.org/10.3390/children9010025
work_keys_str_mv AT morenoramosmiriam incidenceofneonatalabstinencesyndromenasincastillayleonspain
AT sanchezbarbamercedes incidenceofneonatalabstinencesyndromenasincastillayleonspain
AT sanchezrubengarcia incidenceofneonatalabstinencesyndromenasincastillayleonspain
AT mironcanelojoseantonio incidenceofneonatalabstinencesyndromenasincastillayleonspain
AT gonzaleznunezveronica incidenceofneonatalabstinencesyndromenasincastillayleonspain